Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation

British Journal of Clinical Pharmacology

Volumn 55, Issue 1, 2003, Pages 23-31

  Mulla, Hussain ^a,c   Nabi, Fazal ^a   Nichani, Sanjiv ^a   Lawson, Graham ^b   Firmin, R K ^a   Upton, David R ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Extracorporeal membrane oxygenation; Population pharmacokinetics; Theophylline

Indexed keywords

AMINOPHYLLINE; THEOPHYLLINE;

ACCURACY; AGE; ARTICLE; BODY WEIGHT; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; INFANT; KIDNEY; LIVER; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PHYSIOLOGY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

BRONCHODILATOR AGENTS; CHILD, PRESCHOOL; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MODELS, BIOLOGICAL; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; THEOPHYLLINE;

EID: 0037238534     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2003.01735.x     Document Type: Article

References (42)

1. Davis J, Shock N. The effect of theophylline ethylene diamine on renal function in control subjects and in patients with congestive heart failure. J Clin Invest 1949; 28: 1459-1468.
2. Sigurd B, Olesen K. The supra-additive natriuretic effect addition of theophylline ethylenediamine and bumetanide in congestive heart failure. Am Heart J 1977; 94: 168-174.
3. Lochan S, Adeniyi-Jones S, Assadi F, Frey B, Marcus S, Baumgart S. Coadministration of theophylline enhances diuretic response to furosemide in infants during extracorporeal membrane oxygenation. A randomized controlled pilot study. J Pediatr 1998; 133: 86-89.
4. Pretzlaff R, Vardis R, Pollack M. Aminophylline in the treatment of fluid overload. Crit Care Med 1999; 27: 2782-2785.
5. Nassif E, Weinberger M, Shannon D, Guiang S, Hendeles L, Jimenez D et al. Theophylline disposition in infancy. J Pediatrics 1981; 98: 158-161.
6. Moore E, Faix R, Banagale R, Grasela T. The population pharmacokinetics of theophylline in neonates and young infants. J Pharmacokinetics Biopharmaceutics 1989; 17: 47-66.
7. Loughnan P, Sitar D, Ogilvie R, Eisen A, Fox Z, Neims A. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 1976; 88: 874-879.
8. Lee T, Charles B, Steer P, Flenady V, Grant T. Theophylline population pharmacokinetics from routine monitoring data in very premature infants with apnoea. Br J Clin Pharmacol 1996; 41: 191-200.
9. Gilman J, Gal P, Levine R, Hersh C, Vildan Erkan N. Factors influencing theophylline disposition in 179 newborns. Therapeutic Drug Monitoring 1986; 8: 4-10.
10. Elliott E, Koysooko R, Levy G. Pharmacokinetics of theophylline in children with asthma. Pediatrics 1976; 58: 542-547.
11. du Preez M, Botha J, McFayden M, Holford N. The pharmacokinetics of theophylline in premature neonates during the first few days after birth. Therapeutic Drug Monitoring 1999; 21: 598-603.
12. Driscoll M, Ludden T, Casto D, Littlefield L. Evaluation of theophylline pharmacokinetics in a pediatric population using mixed effects models. J Pharmacokinetics Biopharmaceutics 1989; 17: 141-168.
13. Aranda J, Sitar D, Parsons W, Loughnan P, Neims A. Pharmacokinetic aspects of theophylline in premature newborns. N Engl J Med 1976; 295: 413-416.
14. Karlsson M, Thomson A, McGovern E, Chow P, Evans T, Kelman A. Population pharmacokinetics of rectal theophylline in neonates. Therapeutic Drug Monitoring 1991; 13: 195-200.
15. Rosen J, Danish M, Ragni M, Lopez Saccar C, Yaffe S, Lecks H. Theophylline pharmacokinetics in the young infant. Pediatrics 1979; 64 (2): 248-251.
16. Peek G, Killer H, Sosnowski A, Firmin R. Extracorporeal membrane oxygenation: Potential for adults and children? Hospital Med (London) 1998; 59: 304-308.
17. Bartlett R, Roloff D, Custer J, Younger J, Hirschl R. Extracorporeal life support. The University of Michigan Experience. J Am Med Assoc 2000; 283: 904-908.
18. Mulla H, Lawson G, Firmin R, Upton D. Drug disposition during extracorporeal membrane oxygenation (ECMO). Paediatric Perinatal Drug Ther 2001; 4: 109-120.
19. Mulla H, Lawson G, von Anrep C, Burke M, Upton D, Firmin R et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 2000; 15: 21-26.
20. Cohen P, Collart L, Prober C, Fischer A, Blaschke T. Gentamicin pharmacokinetics in neonates undergoing extracorporeal membrane oxygenation. Paediatric Infect Dis 1990; 9: 562-566.
21. Sheiner L, Rosenberg B, Arathe V. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinetics Biopharmaceutics 1977; 5: 445-479.
22. Sheiner L, Grasela T. An introduction to mixed effect modelling, concepts, definitions, and justification. J Pharmacokinetics Biopharmaceutics 1991; 19 (June Suppl.): 11S-24S.
23. Pharsight. Winnonmix Professional, 2.0.1 edn. Mountain View, CA: Pharsight Corp., 1993-2000.
24. Compaq. Compaq Visual Fortran Professional Edition, 6.5 edn. Houston, Compaq Computer Corp., 2000.
25. Sun H, Fadiran E, Jones C, Lesko L, Huang S-M, Higgins K et al. Population pharmacokinetics: A regulatory perspective. Clin Pharmacokinetics 1999; 37: 41-58.
26. Fiset P, Mathers L, Engstrom R, Fitzgerald D, Brand S, Hsu F et al. Pharmacokinetics of computer-controlled alfentanil administration in children undergoing cardiac surgery. Anesthesiology 1995; 83: 944-955.
27. Zomorodi K, Donner A, Somma J, Barr J, Sladen R, Ramsay J et al. Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting. Anesthesiology 1998; 89: 1418-1429.
28. Kerbusch T, Kraker JD, Mathot R, Beijnen J. Population pharmacokinetics of ifosfamide and its dechloroethylated and hydroxylated metabolites in children with malignant disease: A sparse sampling approach. Clin Pharmacokinetics 2001; 40: 615-625.
29. Sheiner L, Beal S. Some suggestions for measuring predictive performance. J Pharmacokinetics Biopharmaceutics 1981; 9: 503-512.
30. Brazier J, Renaud H, Ribon B, Salle B. Serum xanthine levels in low birthweight infants treated or not treated with theophylline. Arch Dis Childhood 1979; 54: 194-199.
31. Jones R, Baillie E. Dosage schedule for intravenous aminophylline in apnoea of prematurity, based on pharmacokinetic studies. Arch Dis Childhood 1979; 54: 190-193.
32. Hilligross D, Jusko W, Koup J, Giacoia G. Factors affecting theophylline pharmacokinetics in premature infants with apnoea. Dev Pharmacol Therapeutics 1980; 1: 6-15.
33. Estelle F, Simons R, Rigatto H, Simons K. Pharmacokinetics of theophylline in neonates. Semin Perinatol 1981; 5: 337-345.
34. Gal P, Boer H, Toback J, Wells T, Erkan N. Effect of asphyxia on theophylline clearance in newborns. Southern Med J 1982; 75: 836-838.
35. MacGillivray T, Jennings R, Rudolph A, Ring E, Adzick N, Harrison M. Vascular changes with in utero correction of diaphragmatic hernia. J Pedia Surg 1994; 29: 992-996.
36. Mckindley D, Hanes S, Boucher B. Hepatic drug metabolism in critical illness. Pharmacotherapy 1998; 18: 759-778.
37. Jusko W, Gardner M, Mangione A, Schentag JJ, Koup JR, Vance JW. Factors affecting theophylline clearance: Age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol. J Pharmaceut Sci 1979; 68: 1358-1366.
38. Self T, Chafin C, Soberman J. Effect of disease states on theophylline serum concentrations: Are we still vigilant? Am J Med Sci 2000; 319: 177-182.
39. ECMO: Extracorporeal Cardiopulmonary Support in Critical Care, 2nd edn, eds Zwischenberger JB, Steinhorn RH, Bartlett RH. Ann Arbor, MI: Extracorporeal Life Support Organization, 2000.
40. Shevde K, Dubois W. Pro: Pulsatile flow is preferable to nonpulsatile flow during cardiopulmonary bypass. J Cardiothoracic Anaesth 1987; 1: 165-168.
41. Rowland M, Tozer T. In Clinical Pharmacokinetics: Concepts and Applications, 3rd edn, eds Fortar JO, Arneil GC. Philadelphia: Lippincott Williams & Wilkins, 1995.
42. Textbook of Paediatrics, 3rd Edn. Edinburgh: Churchill Livingstone, 1984.